PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Acorda Therapeutics, Inc. (ACOR)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS00484M6012
CUSIP00484M601
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$821.03K
EPS (TTM)-$203.57
PEG Ratio0.51
Total Revenue (TTM)$103.69M
Gross Profit (TTM)$81.41M
EBITDA (TTM)$9.78M
Year Range$0.61 - $18.00
Target Price$10.00
Short %0.66%
Short Ratio1.84

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Acorda Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%Sat 30AprilWed 03Fri 05Apr 07Tue 09Thu 11Sat 13Mon 15Wed 17Fri 19Apr 21Tue 23
-99.92%
300.20%
ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

Returns By Period


PeriodReturnBenchmark
Year-To-DateN/A20.30%
1 monthN/A2.61%
6 monthsN/A9.21%
1 yearN/A33.46%
5 years (annualized)N/A14.17%
10 years (annualized)N/A11.29%

Monthly Returns

The table below presents the monthly returns of ACOR, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20246.16%-15.11%-2.86%-95.62%
202323.91%-4.89%-35.14%-20.65%29.03%8.42%17.95%-19.16%20.84%-36.02%2.19%53.98%-1.59%
2022-22.59%10.81%-21.46%-15.53%-62.57%-8.51%-6.61%-6.62%-26.39%257.86%-40.30%20.02%-67.92%
202162.78%-13.65%-16.32%7.19%-28.74%28.23%-21.38%12.80%8.75%-11.52%-36.12%-8.08%-42.28%
2020-0.49%-29.06%-35.24%3.21%-22.33%-1.74%-14.40%-11.53%-7.42%69.75%-23.61%3.34%-66.17%
20196.74%-11.37%-9.84%-21.37%-11.10%-17.44%-9.65%-53.39%-11.15%-42.51%-3.03%27.50%-86.91%
201820.98%-8.48%-0.42%-2.33%13.64%9.33%-13.07%15.43%-31.77%-2.75%6.91%-23.74%-27.37%
20179.04%29.02%-20.60%-23.10%-14.55%42.75%9.90%-3.93%13.70%12.37%-23.61%5.67%14.10%
2016-13.93%-11.16%-19.14%-2.27%10.06%-10.35%-0.88%-4.75%-13.29%-15.23%17.51%-9.62%-56.05%
20151.66%-18.56%-1.65%-9.65%1.36%9.35%3.09%-6.96%-17.08%35.95%5.97%-99.07%-99.13%
20140.51%24.84%3.47%-6.49%-7.25%2.52%-13.17%11.31%3.99%2.77%4.68%13,355.14%16,695.89%
201316.17%3.01%7.66%23.54%-15.47%-1.38%15.10%-11.01%1.21%-10.50%13.72%-99.30%-99.02%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ACOR is 6, indicating that it is in the bottom 6% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of ACOR is 66
ACOR (Acorda Therapeutics, Inc.)
The Sharpe Ratio Rank of ACOR is 1414Sharpe Ratio Rank
The Sortino Ratio Rank of ACOR is 99Sortino Ratio Rank
The Omega Ratio Rank of ACOR is 66Omega Ratio Rank
The Calmar Ratio Rank of ACOR is 22Calmar Ratio Rank
The Martin Ratio Rank of ACOR is 00Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Acorda Therapeutics, Inc. (ACOR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ACOR
Sharpe ratio
No data
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.73, compared to the broader market-4.00-2.000.002.002.73
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.64, compared to the broader market-4.00-2.000.002.004.003.64
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.50, compared to the broader market0.501.001.501.50
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.42, compared to the broader market0.002.004.006.002.42
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 16.69, compared to the broader market0.0010.0020.0016.69

Sharpe Ratio

There is not enough data available to calculate the Sharpe ratio for Acorda Therapeutics, Inc.. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00Sat 30AprilWed 03Fri 05Apr 07Tue 09Thu 11Sat 13Mon 15Wed 17Fri 19Apr 21Tue 23
-0.64
1.92
ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Acorda Therapeutics, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%Sat 30AprilWed 03Fri 05Apr 07Tue 09Thu 11Sat 13Mon 15Wed 17Fri 19Apr 21Tue 23
-100.00%
-3.50%
ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Acorda Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Acorda Therapeutics, Inc. was 100.00%, occurring on Apr 11, 2024. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Jan 27, 20152318Apr 11, 2024
-99.55%Jul 29, 2008802Oct 3, 2011383Apr 15, 20131185
-99.43%Apr 22, 2013181Jan 7, 2014246Dec 29, 2014427
-66.96%Feb 13, 2006155Sep 22, 20061Sep 25, 2006156
-37.5%May 8, 200789Sep 12, 200768Dec 18, 2007157

Volatility

Volatility Chart

The current Acorda Therapeutics, Inc. volatility is 169.22%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%50.00%100.00%150.00%Sat 30AprilWed 03Fri 05Apr 07Tue 09Thu 11Sat 13Mon 15Wed 17Fri 19Apr 21Tue 23
169.22%
3.58%
ACOR (Acorda Therapeutics, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Acorda Therapeutics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Acorda Therapeutics, Inc..


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items